Less Ads, More Data, More Tools Register for FREE

Pin to quick picksReckitt Regulatory News (RKT)

Share Price Information for Reckitt (RKT)

Share Price is delayed by 15 minutes
Get Live Data
4,648.00    108.00 (2.38%)
Bid:
4,623.00
Ask:
4,625.00
Spread: 2.00 (0.043%)
Market Cap: £29.56b
RKT Live PriceLast checked at - London Stock Exchange

Intraday Reckitt Share Chart

Directorate Change

11 Aug 2022 10:27

RNS Number : 7266V
Reckitt Benckiser Group PLC
11 August 2022
Β 

11 August 2022

Β 

Β 

RECKITT BENCKISER GROUP PLC

DIRECTORATE CHANGE

Β 

Reckitt announces the appointment of

Jeremy Darroch as Non-Executive Director

Β 

Β 

Reckitt Benckiser Group plc today announces the appointment of Jeremy Darroch to the Board as a Non-Executive Director and member of the Remuneration Committee, effective 1 November 2022. It is the intention that, following a transition period, he will also succeed Nicandro Durante as the senior independent Non-Executive Director.

Jeremy is the former Executive Chairman and Group Chief Executive of Sky. Jeremy joined Sky PLC as Chief Financial Officer in 2004 and was promoted to Chief Executive Officer in 2007. He stepped down from this position in January 2021, becoming Executive Chairman until the end of that year and remains a senior advisor to the company. Prior to this, Jeremy was Group Finance Director of DSG International plc (formerly Dixons Group plc) and spent 12 years at Procter & Gamble in a variety of roles in the UK and Europe. Jeremy was previously senior independent Non-Executive Director and Chairman of the Audit Committee of Burberry Group plc, and Non-Executive Director and the Chairman of the Audit Committee of Marks and Spencer Group plc. He is also a WWF ambassador and the former Chairman of Business in the Community, the UK's oldest and largest responsible business network.

Commenting on the appointment, Chris Sinclair, Chair of the Board said:

"I am delighted that Jeremy has agreed to join the Reckitt Board. He is an outstanding leader, with considerable expertise in the consumer retail environment built up over a successful career at some of the UK's most high-profile companies. He has a proven track record of driving business performance and a unique insight into what motivates consumers, and we welcome the value he will bring to the Board."

The Company confirms that there is no further information to be disclosed under the requirements of Listing Rule 9.6.13R in relation to Jeremy Darroch's appointment.

Β 

Β 

For further Information:

Catheryn O'Rourke

Company Secretary

Tel +44 (0) 1753 217 800

Β 

Β 

Richard Joyce

Head of Investor Relations

Tel +44 (0) 7408 812 062

Β 

Reckitt Benckiser Group plc's LEI code is 5493003JFSMOJG48V108

Β Β 

About Reckitt:

Β 

Reckitt* exists to protect, heal and nurture in the relentless pursuit of a cleaner, healthier world. We believe thatΒ access to the highest-quality hygiene, wellness and nourishment is a right, not a privilege.

Β 

Reckitt is the company behind some of the world's most recognisable and trusted consumer brands in hygiene, health and nutrition, including Air Wick, Calgon, Cillit Bang, Clearasil, Dettol, Durex, Enfamil, Finish, Gaviscon, Harpic, Lysol, Mortein, Mucinex, Nurofen, Nutramigen, Strepsils, Vanish, Veet, Woolite and more.

Β 

Every day, more than 20 million Reckitt products are bought globally. We always put consumers and people first, seek out new opportunities, strive for excellence in all that we do and build shared success with all our partners. We aim to do the right thing, always.

Β 

We are a diverse global team of more thanΒ 43,000 colleagues.Β We draw on our collective energy to meet our ambitions of purpose-led brands, a healthier planet and a fairer society. Find out more, or get in touch with us atΒ www.reckitt.com

Β 

*Reckitt is the trading name of the Reckitt Benckiser group of companies

Β 

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
BOAGPUAPRUPPUBG
Date   Source Headline
10th Jun 20267:00 amRNSTransaction in Own Shares
9th Jun 20267:00 amRNSTransaction in Own Shares
8th Jun 20262:30 pmRNSEMTN Programme: Publication of Final Terms
8th Jun 20267:00 amRNSTransaction in Own Shares
5th Jun 20267:00 amRNSTransaction in Own Shares
4th Jun 20267:00 amRNSTransaction in Own Shares
3rd Jun 20267:00 amRNSTransaction in Own Shares
2nd Jun 20261:26 pmRNSDirector/PDMR Shareholding
2nd Jun 20267:00 amRNSTransaction in Own Shares
1st Jun 20265:32 pmRNSDirector/PDMR Shareholding
1st Jun 20262:05 pmRNSTotal Voting Rights
1st Jun 20267:00 amRNSTransaction in Own Shares
29th May 20267:00 amRNSTransaction in Own Shares
28th May 20267:00 amRNSTransaction in Own Shares
27th May 20267:00 amRNSTransaction in Own Shares
26th May 20265:42 pmRNSEMTN Programme: Publication of Final Terms
26th May 20267:00 amRNSTransaction in Own Shares
22nd May 20267:00 amRNSTransaction in Own Shares
21st May 20264:44 pmRNSResult of AGM
21st May 20267:00 amRNSTransaction in Own Shares
20th May 20267:00 amRNSTransaction in Own Shares
19th May 20267:00 amRNSTransaction in Own Shares
18th May 20267:00 amRNSTransaction in Own Shares
15th May 202610:18 amRNSPublication of Supplementary Prospectus
15th May 20267:00 amRNSTransaction in Own Shares
14th May 20267:00 amRNS‘RECKITT FOCUS ON’ INVESTOR SEMINAR
14th May 20267:00 amRNSTransaction in Own Shares
13th May 20267:00 amRNSTransaction in Own Shares
12th May 20267:00 amRNSTransaction in Own Shares
11th May 20267:00 amRNSTransaction in Own Shares
8th May 20267:00 amRNSTransaction in Own Shares
7th May 20267:00 amRNSTransaction in Own Shares
6th May 20267:00 amRNSTransaction in Own Shares
5th May 20267:00 amRNSTransaction in Own Shares
1st May 20262:51 pmRNSTotal Voting Rights
1st May 20267:00 amRNSTransaction in Own Shares
30th Apr 20267:00 amRNSTransaction in Own Shares
29th Apr 20263:30 pmRNSDirector/PDMR Shareholding
29th Apr 20267:00 amRNSTransaction in Own Shares
28th Apr 20267:00 amRNSTransaction in Own Shares
27th Apr 20267:00 amRNSTransaction in Own Shares
24th Apr 20267:00 amRNSTransaction in Own Shares
23rd Apr 20263:00 pmRNSDirector Declaration
23rd Apr 20267:00 amRNSTransaction in Own Shares
22nd Apr 20267:00 amRNSQ1 RESULTS 2026
22nd Apr 20267:00 amRNSTransaction in Own Shares
21st Apr 20267:00 amRNSTransaction in Own Shares
20th Apr 20267:00 amRNSTransaction in Own Shares
17th Apr 20267:00 amRNSTransaction in Own Shares
16th Apr 20267:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.